| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.721 | 0.005 | 0.721 | Immunomodulator | 0.668 0.007 CHEMBL3527332 | ||
| 0.714 | 0.001 | 0.714 | Glutamate release inhibitor | 0.24 0.004 CHEMBL3527332 | ||
| 0.699 | 0.004 | 0.699 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.587 | 0.019 | 0.587 | Toll-Like receptor agonist | |||
| 0.57 | 0.021 | 0.57 | Toll-Like receptor 7 agonist | |||
| 0.441 | 0.022 | 0.441 | HERG channel blocker | |||
| 0.424 | 0.007 | 0.424 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.419 | 0.006 | 0.419 | c-Src kinase inhibitor | |||
| 0.442 | 0.044 | 0.442 | GABA C receptor rho-3 antagonist | |||
| 0.389 | 0.008 | 0.389 | Nav1.2 sodium channel blocker | |||
| 0.384 | 0.03 | 0.384 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.365 | 0.016 | 0.365 | Src kinase inhibitor | |||
| 0.356 | 0.011 | 0.356 | LIM domain kinase 1 inhibitor | |||
| 0.342 | 0.012 | 0.342 | Protein kinase (CK1) gamma inhibitor | |||
| 0.337 | 0.019 | 0.337 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.183 0.09 CHEMBL3527332 | ||
| 0.318 | 0.009 | 0.318 | Sodium channel blocker | |||
| 0.311 | 0.009 | 0.311 | Heat shock protein 90 antagonist | |||
| 0.324 | 0.03 | 0.324 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.31 | 0.034 | 0.31 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.369 | 0.1 | 0.369 | 5 Hydroxytryptamine release inhibitor | |||
| 0.302 | 0.04 | 0.302 | Anticonvulsant | |||
| 0.258 | 0.005 | 0.258 | Folate antagonist | 0.162 0.018 CHEMBL3527332 | ||
| 0.289 | 0.041 | 0.289 | Death-associated protein kinase 3 inhibitor | |||
| 0.259 | 0.024 | 0.259 | Heat shock protein 90 alpha antagonist | |||
| 0.237 | 0.005 | 0.237 | Electrolyte absorption antagonist | |||
| 0.234 | 0.008 | 0.234 | Adenosine A2 receptor antagonist | 0.2 0.01 CHEMBL3527332 | ||
| 0.264 | 0.043 | 0.264 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.229 | 0.008 | 0.229 | Adenosine A2a receptor antagonist | 0.201 0.01 CHEMBL3527332 | ||
| 0.223 | 0.009 | 0.333 | Adenosine A1 receptor antagonist | 0.333 0.005 CHEMBL3527332 | CHEMBL3527332 | |
| 0.245 | 0.036 | 0.245 | Nitric-oxide synthase stimulant | |||
| 0.252 | 0.048 | 0.315 | RNA-directed DNA polymerase inhibitor | 0.315 0.029 CHEMBL3527332 | CHEMBL3527332 | |
| 0.225 | 0.021 | 0.225 | Sodium channel (voltage-gated) blocker | |||
| 0.256 | 0.058 | 0.256 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.149 0.147 CHEMBL3527332 | ||
| 0.243 | 0.048 | 0.243 | CDC-like kinase 2 inhibitor | |||
| 0.222 | 0.043 | 0.222 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.2 | 0.024 | 0.2 | Ephrin antagonist | |||
| 0.226 | 0.06 | 0.226 | Tyrosine kinase inhibitor | |||
| 0.222 | 0.057 | 0.222 | CDC-like kinase 4 inhibitor | |||
| 0.334 | 0.169 | 0.334 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.207 | 0.043 | 0.207 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.187 | 0.027 | 0.187 | Interleukin 4 antagonist | 0.146 0.054 CHEMBL3527332 | ||
| 0.225 | 0.066 | 0.225 | Clk dual-specificity kinase inhibitor | |||
| 0.214 | 0.055 | 0.214 | Peroxidase inhibitor | |||
| 0.236 | 0.078 | 0.236 | Antiamyloidogenic | |||
| 0.19 | 0.032 | 0.19 | Protein kinase (CK1) delta inhibitor | |||
| 0.233 | 0.08 | 0.233 | Dyrk kinase inhibitor | |||
| 0.188 | 0.035 | 0.188 | Cell wall synthesis inhibitor | 0.167 0.05 CHEMBL3527332 | ||
| 0.161 | 0.009 | 0.161 | Purinergic P2X2 antagonist | 0.141 0.014 CHEMBL3527332 | ||
| 0.193 | 0.042 | 0.193 | Protein kinase (CK1) inhibitor | |||
| 0.22 | 0.081 | 0.22 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.145 | 0.006 | 0.145 | Adenosine A2b receptor antagonist | 0.054 0.03 CHEMBL3527332 | ||
| 0.207 | 0.072 | 0.207 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.144 | 0.013 | 0.144 | Interleukin 5 antagonist | 0.086 0.062 CHEMBL3527332 | ||
| 0.177 | 0.049 | 0.177 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.161 | 0.036 | 0.161 | Protein kinase (CK2) alpha inhibitor | |||
| 0.193 | 0.071 | 0.193 | TRKC antagonist | |||
| 0.252 | 0.133 | 0.433 | Vasodilator, coronary | 0.433 0.026 CHEMBL3527332 | CHEMBL3527332 | |
| 0.139 | 0.025 | 0.139 | Interleukin 2 antagonist | |||
| 0.119 | 0.007 | 0.119 | Heat shock protein 90 beta antagonist | |||
| 0.137 | 0.027 | 0.137 | Phosphodiesterase 7B inhibitor | |||
| 0.146 | 0.038 | 0.146 | MAP kinase 13 inhibitor | |||
| 0.123 | 0.015 | 0.123 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.123 | 0.017 | 0.39 | Adenosine A3 receptor antagonist | 0.39 0.004 CHEMBL3527332 | CHEMBL3527332 | |
| 0.148 | 0.043 | 0.148 | MAP kinase 12 inhibitor | |||
| 0.204 | 0.1 | 0.204 | Aryl hydrocarbon receptor agonist | |||
| 0.165 | 0.065 | 0.178 | Diuretic | 0.178 0.055 CHEMBL3527332 | CHEMBL3527332 | |
| 0.159 | 0.061 | 0.159 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.107 | 0.01 | 0.108 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.108 0.009 CHEMBL3527332 | CHEMBL3527332 | |
| 0.161 | 0.064 | 0.161 | Protein kinase C nu inhibitor | |||
| 0.119 | 0.027 | 0.119 | AXL receptor tyrosine kinase inhibitor | |||
| 0.115 | 0.026 | 0.115 | Factor XII inhibitor | |||
| 0.093 | 0.004 | 0.093 | Dihydrofolate reductase inhibitor | |||
| 0.151 | 0.064 | 0.151 | Ribosomal protein S6 kinase inhibitor | |||
| 0.108 | 0.025 | 0.108 | mTOR complex 2 inhibitor | |||
| 0.098 | 0.015 | 0.098 | Phosphodiesterase VIII inhibitor | 0.07 0.053 CHEMBL3527332 | ||
| 0.199 | 0.116 | 0.199 | DNA damaging | |||
| 0.116 | 0.033 | 0.116 | Histamine N-methyltransferase inhibitor | |||
| 0.114 | 0.032 | 0.222 | NADH dehydrogenase inhibitor | 0.222 0.009 CHEMBL3527332 | CHEMBL3527332 | |
| 0.201 | 0.121 | 0.428 | DNA synthesis inhibitor | 0.428 0.019 CHEMBL3527332 | CHEMBL3527332 | |
| 0.144 | 0.069 | 0.144 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.113 | 0.044 | 0.113 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.172 | 0.104 | 0.244 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.244 0.045 CHEMBL3527332 | CHEMBL3527332 | |
| 0.13 | 0.063 | 0.13 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.171 | 0.105 | 0.171 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.126 | 0.061 | 0.126 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.12 | 0.057 | 0.12 | Polo-like kinase-4 inhibitor | |||
| 0.084 | 0.022 | 0.084 | EphB4 antagonist | |||
| 0.114 | 0.052 | 0.114 | Protein kinase (CK2) inhibitor | |||
| 0.091 | 0.03 | 0.091 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.166 | 0.107 | 0.166 | MAP kinase kinase 2 inhibitor | |||
| 0.141 | 0.083 | 0.141 | MAP kinase 3 inhibitor | |||
| 0.171 | 0.115 | 0.171 | Potassium channel blocker | |||
| 0.085 | 0.032 | 0.085 | CDC7 inhibitor | |||
| 0.116 | 0.067 | 0.116 | Aurora-B kinase inhibitor | |||
| 0.14 | 0.096 | 0.14 | Polo-like kinase-3 inhibitor | |||
| 0.054 | 0.011 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.109 | 0.066 | 0.109 | EphA2 antagonist | |||
| 0.136 | 0.095 | 0.136 | GABA C receptor rho-2 antagonist | |||
| 0.067 | 0.028 | 0.101 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.101 0.014 CHEMBL3527332 | CHEMBL3527332 | |
| 0.126 | 0.086 | 0.126 | Nav1.6 sodium channel blocker | |||
| 0.059 | 0.02 | 0.059 | Histamine H4 receptor antagonist | |||
| 0.131 | 0.093 | 0.131 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.157 | 0.12 | 0.157 | Focal adhesion kinase 2 inhibitor | |||
| 0.095 | 0.059 | 0.095 | Toll-Like receptor 3 antagonist | |||
| 0.111 | 0.077 | 0.111 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.058 | 0.024 | 0.058 | Purinergic P2X antagonist | |||
| 0.11 | 0.077 | 0.11 | Abl kinase inhibitor | |||
| 0.18 | 0.146 | 0.18 | Streptokinase A inhibitor | |||
| 0.075 | 0.042 | 0.075 | Secretase beta inhibitor | |||
| 0.132 | 0.1 | 0.132 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.099 | 0.068 | 0.099 | Carbonic anhydrase XV inhibitor | |||
| 0.048 | 0.018 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.077 | 0.048 | 0.077 | GABA B receptor agonist | |||
| 0.104 | 0.077 | 0.104 | Nav1.5 sodium channel blocker | |||
| 0.043 | 0.017 | 0.088 | Phosphoglycerate kinase inhibitor | 0.088 0.008 CHEMBL3527332 | CHEMBL3527332 | |
| 0.03 | 0.005 | 0.03 | Toll-Like receptor 8 agonist | |||
| 0.075 | 0.049 | 0.075 | Nav1.8 sodium channel blocker | |||
| 0.059 | 0.033 | 0.059 | Cyclin B inhibitor | |||
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | 0.048 0.036 CHEMBL3527332 | ||
| 0.129 | 0.105 | 0.174 | Hexokinase inhibitor | 0.174 0.055 CHEMBL3527332 | CHEMBL3527332 | |
| 0.047 | 0.024 | 0.047 | Guanylate cyclase stimulant | |||
| 0.083 | 0.061 | 0.083 | D-Ala-D-Ala ligase inhibitor | |||
| 0.096 | 0.075 | 0.096 | Ferrochelatase inhibitor | |||
| 0.084 | 0.065 | 0.084 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.04 | 0.022 | 0.04 | Growth hormone secretagogue receptor antagonist | |||
| 0.039 | 0.024 | 0.039 | Integrin alpha1beta1 antagonist | |||
| 0.09 | 0.077 | 0.09 | Insulin receptor antagonist | |||
| 0.096 | 0.082 | 0.096 | Cystathionine beta-synthase inhibitor | |||
| 0.062 | 0.049 | 0.062 | Interferon inducer | |||
| 0.059 | 0.049 | 0.059 | Purinergic P2 antagonist | |||
| 0.032 | 0.021 | 0.032 | Potassium channel small-conductance Ca-activated activator | |||
| 0.045 | 0.035 | 0.045 | Thymidylate synthase inhibitor | |||
| 0.027 | 0.017 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 CHEMBL3527332 | CHEMBL3527332 | |
| 0.129 | 0.12 | 0.129 | CF transmembrane conductance regulator agonist | |||
| 0.064 | 0.055 | 0.064 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.082 | 0.073 | 0.082 | Pim-3 kinase inhibitor | |||
| 0.073 | 0.065 | 0.073 | Interferon agonist | |||
| 0.123 | 0.117 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.018 | 0.013 | 0.018 | Cyclin T1 inhibitor | |||
| 0.091 | 0.085 | 0.144 | Adenylate kinase inhibitor | 0.144 0.029 CHEMBL3527332 | CHEMBL3527332 | |
| 0.027 | 0.023 | 0.035 | Purinergic P2Y15 antagonist | 0.035 0.01 CHEMBL3527332 | CHEMBL3527332 | |
| 0.097 | 0.093 | 0.097 | Beta amyloid protein antagonist | |||
| 0.031 | 0.029 | 0.031 | Purinergic P2X7 antagonist | |||
| 0.007 | 0.005 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.019 | 0.017 | 0.034 | Adenosine kinase inhibitor | 0.034 0.009 CHEMBL3527332 | CHEMBL3527332 | |
| 0.08 | 0.078 | 0.202 | Aminoacyl-tRNA synthetase inhibitor | 0.202 0.01 CHEMBL3527332 | CHEMBL3527332 | |
| 0.054 | 0.053 | 0.089 | Purinergic P2X1 antagonist | 0.089 0.021 CHEMBL3527332 | CHEMBL3527332 | |
| 0.039 | 0.04 | 0.049 | AICAR transformylase inhibitor | 0.049 0.024 CHEMBL3527332 | CHEMBL3527332 | |
| 0.013 | 0.014 | 0.027 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.027 0.005 CHEMBL3527332 | CHEMBL3527332 | |
| 0.022 | 0.024 | 0.041 | Purinergic P2X agonist | 0.041 0.012 CHEMBL3527332 | CHEMBL3527332 | |
| 0.012 | 0.016 | 0.021 | Adenosine A2b receptor agonist | 0.021 0.005 CHEMBL3527332 | CHEMBL3527332 | |
| 0.05 | 0.055 | 0.085 | Carbamoyl phosphate synthetase inhibitor | 0.085 0.026 CHEMBL3527332 | CHEMBL3527332 | |
| 0.014 | 0.02 | 0.021 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.021 0.006 CHEMBL3527332 | CHEMBL3527332 | |
| 0.104 | 0.115 | 0.18 | DNA repair enzyme inhibitor | 0.18 0.013 CHEMBL3527332 | CHEMBL3527332 | |
| 0.061 | 0.072 | 0.096 | Glutamate dehydrogenase inhibitor | 0.096 0.033 CHEMBL3527332 | CHEMBL3527332 | |
| 0.008 | 0.02 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 CHEMBL3527332 | CHEMBL3527332 | |
| 0.009 | 0.023 | 0.021 | Adenosine A2a receptor agonist | 0.021 0.008 CHEMBL3527332 | CHEMBL3527332 | |
| 0.012 | 0.029 | 0.024 | Adenosine A3 receptor agonist | 0.024 0.006 CHEMBL3527332 | CHEMBL3527332 | |
| 0.033 | 0.049 | 0.04 | Thymidine kinase inhibitor | 0.04 0.03 CHEMBL3527332 | CHEMBL3527332 | |
| 0.126 | 0.144 | 0.401 | DNA methylase inhibitor | 0.401 0.011 CHEMBL3527332 | CHEMBL3527332 | |
| 0.01 | 0.03 | 0.022 | Adenosine A2 receptor agonist | 0.022 0.007 CHEMBL3527332 | CHEMBL3527332 | |
| 0.075 | 0.096 | 0.085 | DNA directed RNA polymerase inhibitor | 0.085 0.077 CHEMBL3527332 | CHEMBL3527332 | |
| 0.039 | 0.065 | 0.077 | Argininosuccinate synthase inhibitor | 0.077 0.027 CHEMBL3527332 | CHEMBL3527332 | |
| 0.021 | 0.05 | 0.039 | Fumarate hydratase inhibitor | 0.039 0.02 CHEMBL3527332 | CHEMBL3527332 | |
| 0.029 | 0.06 | 0.071 | Adenosine deaminase inhibitor | 0.071 0.013 CHEMBL3527332 | CHEMBL3527332 | |
| 0.015 | 0.048 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 CHEMBL3527332 | CHEMBL3527332 | |
| 0.139 | 0.173 | 0.183 | Cyclic AMP phosphodiesterase inhibitor | 0.183 0.108 CHEMBL3527332 | CHEMBL3527332 | |
| 0.115 | 0.153 | 0.356 | DNA methyltransferase I inhibitor | 0.356 0.013 CHEMBL3527332 | CHEMBL3527332 | |
| 0.041 | 0.085 | 0.126 | Phosphofructokinase-1 inhibitor | 0.126 0.024 CHEMBL3527332 | CHEMBL3527332 | |
| 0.037 | 0.082 | 0.063 | Biliverdin reductase inhibitor | 0.063 0.038 CHEMBL3527332 | CHEMBL3527332 | |
| 0.123 | 0.168 | 0.141 | Heat shock protein 70 antagonist | 0.141 0.071 CHEMBL3527332 | CHEMBL3527332 | |
| 0.068 | 0.115 | 0.159 | UDP-glucose 4-epimerase inhibitor | 0.159 0.026 CHEMBL3527332 | CHEMBL3527332 | |
| 0.003 | 0.055 | 0.016 | Purinergic P2 agonist | 0.016 0.01 CHEMBL3527332 | CHEMBL3527332 | |
| 0.003 | 0.055 | 0.016 | Purinergic receptor agonist | 0.016 0.01 CHEMBL3527332 | CHEMBL3527332 | |
| 0.003 | 0.056 | 0.012 | Purinergic P2Y agonist | 0.012 0.009 CHEMBL3527332 | CHEMBL3527332 | |
| 0.01 | 0.063 | 0.042 | Adenosine A1 receptor agonist | 0.042 0.007 CHEMBL3527332 | CHEMBL3527332 | |
| 0.229 | 0.292 | 0.344 | Antiinflammatory | 0.344 0.177 CHEMBL3527332 | CHEMBL3527332 | |
| 0.023 | 0.086 | 0.059 | Antimetabolite | 0.059 0.026 CHEMBL3527332 | CHEMBL3527332 | |
| 0.15 | 0.222 | 0.237 | Cholesterol antagonist | 0.237 0.135 CHEMBL3527332 | CHEMBL3527332 | |
| 0.109 | 0.203 | 0.424 | Immunostimulant | 0.424 0.043 CHEMBL3527332 | CHEMBL3527332 | |
| 0.061 | 0.156 | 0.125 | Adenylate cyclase inhibitor | 0.125 0.063 CHEMBL3527332 | CHEMBL3527332 | |
| 0.007 | 0.113 | 0.021 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.021 0.013 CHEMBL3527332 | CHEMBL3527332 | |
| 0.051 | 0.184 | 0.085 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.073 CHEMBL3527332 | CHEMBL3527332 | |
| 0.026 | 0.173 | 0.07 | Factor IXa inhibitor | 0.07 0.02 CHEMBL3527332 | CHEMBL3527332 | |
| 0.071 | 0.277 | 0.12 | NOS3 expression enhancer | 0.12 0.116 CHEMBL3527332 | CHEMBL3527332 | |
| 0.122 | 0.35 | 0.381 | Antibacterial | 0.381 0.086 CHEMBL3527332 | CHEMBL3527332 | |
| 0.032 | 0.418 | 0.192 | DNA polymerase I inhibitor | 0.192 0.031 CHEMBL3527332 | CHEMBL3527332 | |
| 0.075 | 0.658 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.03 CHEMBL3527332 | CHEMBL3527332 | |
| 0.066 | 0.695 | 0.213 | Interleukin 2 agonist | 0.213 0.168 CHEMBL3527332 | CHEMBL3527332 | |
| 0.017 | 0.67 | 0.231 | Vasodilator | 0.231 0.081 CHEMBL3527332 | CHEMBL3527332 | |
| 0.009 | 0.706 | 0.034 | Antibiotic Aminoglycoside-like | 0.034 0.029 CHEMBL3527332 | CHEMBL3527332 | |
| 0.027 | 0.738 | 0.168 | Hepatoprotectant | 0.168 0.091 CHEMBL3527332 | CHEMBL3527332 | |
| 0.012 | 0.756 | 0.463 | Angiogenesis stimulant | 0.463 0.014 CHEMBL3527332 | CHEMBL3527332 | |
| 0.005 | 0.813 | 0.123 | Topoisomerase I inhibitor | 0.123 0.054 CHEMBL3527332 | CHEMBL3527332 | |
| 0.006 | 0.815 | 0.049 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 CHEMBL3527332 | CHEMBL3527332 | |
| 0.006 | 0.903 | 0.123 | Thrombolytic | 0.123 0.107 CHEMBL3527332 | CHEMBL3527332 | |
| 0.007 | 0.921 | 0.302 | Apoptosis agonist | 0.302 0.17 CHEMBL3527332 | CHEMBL3527332 | |
| 0.008 | 0.931 | 0.155 | Platelet adhesion inhibitor | 0.155 0.1 CHEMBL3527332 | CHEMBL3527332 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |